NRBO   $3.3585000000000003  -3.77% Market Open

NeuroBo Pharmaceuticals Inc
Total Cash 28.05M
totalCashPerShare 3.315
EBITDA -26.51M
Total Debt 170.00K
quickRatio 2.888
currentRatio 2.937
Total Revenue
debtToEquity 0.897
Revenue/Share
ROA -0.57235
ROE -1.17355
grossProfits
freeCashflow -10.44M
operatingCashflow -19.90M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 2.66M
forwardPE -2.0917058
floatShares 2.06M
sharesOutstanding 8.49M
sharesShort 28.12K
sharesShortPriorMonth 32.79K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.66%
heldPercentInstitutions 0.12%
Short Ratio help_outline 1.03%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 2.304
Price To Book help_outline 1.54
earningsQuarterlyGrowth
netIncomeToCommon -25.90M
trailingEps -4.99%
forwardEps -1.70%
enterpriseToEbitda -0.10
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.73 3Q 2024
institutionsCount 13
lastUpdated Sept. 16, 2024, 7:48 p.m.